Evidence map›Paper›PMID 38700287›Full record

ReviewFuture microbiology2024

Severe mold fungal infections in critically ill patients with COVID-19.

Despoina Koulenti, Elisabeth Paramythiotou, Maria Panagiota Almyroudi, Marios Karvouniaris, Nikolaos Markou, Paschalis Paranos, Christina Routsi, Joseph Meletiadis, Stijn Blot

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Future microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Journal of fungi (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Despoina KoulentiDepartment of Critical Care Medicine, King's College Hospital NHS Foundation Trust, London, UK.ORCID 0000-0003-4364-2612
Elisabeth ParamythiotouSecond Critical Care Department, Attikon University Hospital, Athens, Greece.ORCID 0000-0001-5779-6597
Maria Panagiota AlmyroudiEmergency Department, Attikon University Hospital, National & Kapodistrian University of Athens, Greece.ORCID 0000-0001-6107-9160
Marios KarvouniarisIntensive Care Unit, AHEPA University Hospital, Thessaloniki, Greece.ORCID 0000-0003-0419-2639
Nikolaos MarkouIntensive Care Unit of Latseio Burns Centre, Thriasio General Hospital of Elefsina, Greece.
Paschalis ParanosClinical Microbiology Laboratory, Attikon University Hospital, National & Kapodistrian Uni-versity of Athens, Greece.ORCID 0000-0003-1934-8691
Christina RoutsiFirst Department of Intensive Care, School of Medicine, National & Kapodistrian University of Athens, Evangelismos General Hospital, Athens, Greece.ORCID 0000-0002-5871-1361
Joseph MeletiadisClinical Microbiology Laboratory, Attikon University Hospital, National & Kapodistrian Uni-versity of Athens, Greece.
Stijn BlotUQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Australia.ORCID 0000-0003-2145-0345

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The SARS-CoV-2 pandemic put an unprecedented strain on modern societies and healthcare systems. A significantly higher incidence of invasive fungal co-infections was noted compared with the pre-COVID-19 era, adding new diagnostic and therapeutic challenges in the critical care setting. In the current narrative review, we focus on invasive mold infections caused by

Indexed as

CoinfectionCOVID-19Critical IllnessInvasive Fungal InfectionsMucormycosisSARS-CoV-2Antifungal AgentsAspergillosisAspergillusHumansIncidenceMucorRisk FactorsAntifungal AgentsantifungalsaspergillosisCAMCAPACOVID-19critical illnessmoldsmucormycosis

Identifiers

PMID38700287
PMCPMC11290760

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.